z-logo
open-access-imgOpen Access
Is the Interruption of Antiretroviral Treatment During Pregnancy an Additional Major Risk Factor for Mother‐to‐Child Transmission of HIV Type 1?
Author(s) -
Luisa Galli,
Donella Puliti,
Elena Chiappini,
Clara Gabiano,
G. Ferraris,
F Mig,
M Viganò,
Carlo Giaquinto,
Orazio Genovese,
Gianfranco Anzidei,
Raffaele Badolato,
Wilma Buffolano,
Anna Maccabruni,
Filippo Salvini,
Monica Cellini,
Maurizio Ruggeri,
Mariano Manzionna,
Stefania Bernardi,
PierAngelo Tovo,
Maurizio de Martino
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/597774
Subject(s) - medicine , interquartile range , pregnancy , odds ratio , confidence interval , viral load , prospective cohort study , cohort , obstetrics , cohort study , logistic regression , confounding , gestation , pediatrics , human immunodeficiency virus (hiv) , surgery , immunology , genetics , biology
There is currently an experts' agreement discouraging interruption of antiretroviral treatment (ART) during the first trimester of pregnancy in women infected with human immunodeficiency virus type 1 (HIV-1). However, this recommendation is poorly supported by data. We evaluated the effects of discontinuing ART during pregnancy on the rate of mother-to-child transmission.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom